Refine Search
(0)
(0)
(4)
(11)

Infectious Diseases

Infectious diseases are the second most researched therapy area with over 4,200 pipeline drugs. Close to 70% of the pipeline drugs are in the early stages of development. Research for the treatment of infectious diseases is dominated by vaccines, small molecules and antibodies. Haemagglutinin, respiratory syncytial virus F (RSV-F) protein and reverse transcriptase are some of the major drug targets in research for infectious diseases.

Malaria - Pipeline Review, H1 2018

  • $2,000
  • May 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Malaria - Pipeline Review, H1 2018’, provides an overview of the Malaria pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Malaria, complete with analysi...

Meningitis - Pipeline Review, H1 2018

  • $2,000
  • June 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Meningitis - Pipeline Review, H1 2018’, provides an overview of the Meningitis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Meningitis, complete wit...

Pertussis (Whooping Cough) - Pipeline Review, H1 2018

  • $2,000
  • June 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Pertussis (Whooping Cough) - Pipeline Review, H1 2018’, provides an overview of the Pertussis (Whooping Cough) pipeline landscape.

The report provides comprehensive information on the therapeutics under developm...

Zika Virus Infections - Pipeline Review, H1 2018

  • $2,000
  • June 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Zika Virus Infections - Pipeline Review, H1 2018’, provides an overview of the Zika Virus Infections pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Zi...

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections - Pipeline Review, H1 2018

  • $2,000
  • May 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Methicillin-Resistant Staphylococcus aureus (MRSA) Infections - Pipeline Review, H1 2018’, provides an overview of the Methicillin-Resistant Staphylococcus aureus (MRSA) Infections pipeline landscape.

The report...

Impetigo - Pipeline Review, H1 2018

  • $2,000
  • May 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Impetigo - Pipeline Review, H1 2018’, provides an overview of the Impetigo pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Impetigo, complete with anal...

Herpes Labialis (Oral Herpes) - Pipeline Review, H2 2018

  • $2,000
  • November 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Herpes Labialis (Oral Herpes) - Pipeline Review, H2 2018’, provides an overview of the Herpes Labialis (Oral Herpes) pipeline landscape.

The report provides comprehensive information on the therapeutics under de...

Warts - Pipeline Review, H1 2019

  • $2,000
  • February 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Warts - Pipeline Review, H1 2019’, provides an overview of the Warts pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Warts, complete with analysis by s...

Plague - Pipeline Review, H1 2019

  • $2,000
  • February 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Plague - Pipeline Review, H1 2019’, provides an overview of the Plague pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Plague, complete with analysis b...

Hospital Acquired Pneumonia (HAP) - Pipeline Review, H1 2019

  • $2,000
  • February 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Hospital Acquired Pneumonia (HAP) - Pipeline Review, H1 2019’, provides an overview of the Hospital Acquired Pneumonia (HAP) pipeline landscape.

The report provides comprehensive information on the therapeutics ...

Human Immunodeficiency Virus (HIV) Infections (AIDS) - Pipeline Review, H1 2018

  • $2,500
  • June 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Human Immunodeficiency Virus (HIV) Infections (AIDS) - Pipeline Review, H1 2018’, provides an overview of the Human Immunodeficiency Virus (HIV) Infections (AIDS) pipeline landscape.

The report provides comprehen...